Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia

Anthracyclines constitute the backbone of intensive adult acute myeloid leukemia (AML) therapy. Cardiotoxicity is one of its most serious adverse effects, and its incidence increases with cumulative dose. Dexrazoxane is a cardioprotective agent used in conjunction with anthracycline therapy. There i...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Leuk Res Rep
Auteurs principaux: Vachhani, Pankit, Shin, Sarah, Baron, Jeffrey, Thompson, James E., Wetzler, Meir, Griffiths, Elizabeth A., Ontiveros, Evelena P., Spangenthal, Edward J., Wang, Eunice S.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2017
Sujets:
Full Length Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5402627/
https://ncbi.nlm.nih.gov/pubmed/28462084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2017.04.001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires